摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-3-biphenyl-4-ylmethyl-N-(3-carboxy-propyl)succinamic acid tert-butyl ester | 1257446-46-0

中文名称
——
中文别名
——
英文名称
(R)-3-biphenyl-4-ylmethyl-N-(3-carboxy-propyl)succinamic acid tert-butyl ester
英文别名
4-[[(2R)-4-[(2-methylpropan-2-yl)oxy]-4-oxo-2-[(4-phenylphenyl)methyl]butanoyl]amino]butanoic acid
(R)-3-biphenyl-4-ylmethyl-N-(3-carboxy-propyl)succinamic acid tert-butyl ester化学式
CAS
1257446-46-0
化学式
C25H31NO5
mdl
——
分子量
425.525
InChiKey
LKNSHSXTGQMOQV-OAQYLSRUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    31
  • 可旋转键数:
    12
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    92.7
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS
    申请人:COPPOLA Gary Mark
    公开号:US20140296240A1
    公开(公告)日:2014-10-02
    The present invention provides a compound of formula I′; or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 5 , B 1 , X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    本发明提供了式I'的化合物;或其药学上可接受的盐,其中R1、R2、R3、R5、B1、X和n在此定义。本发明还涉及制造本发明化合物的方法及其治疗用途。本发明还提供了一种药理活性剂的组合和制药组合物。
  • Substituted Aminopropionic Derivatives as Neprilysin inhibitors
    申请人:Coppola Gary Mark
    公开号:US20100305131A1
    公开(公告)日:2010-12-02
    The present invention provides a compound of formula I′; or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 5 , B 1 , X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    本发明提供了式I'的化合物;或其药学上可接受的盐,其中R1、R2、R3、R5、B1、X和n在此定义。本发明还涉及制造该化合物的方法及其治疗用途。本发明进一步提供了一种药理活性剂的组合和制药组合物。
  • POLYCARBONATE RESIN COMPOSITION, AND MOLDED ARTICLE, FILM, PLATE AND INJECTION-MOLDED ARTICLE EACH COMPRISING SAME
    申请人:Mitsubishi Chemical Corporation
    公开号:EP2594608A1
    公开(公告)日:2013-05-22
    The invention is to provide a polycarbonate resin composition and a molded polycarbonate resin article which combine excellent transparency and strength and which are suitable for use in the field of building materials, electrical/electronic field, automotive field, field of optical parts, etc. The invention relates to a polycarbonate resin composition containing a polycarbonate resin and an impact strength modifier, the polycarbonate resin containing structural units which are derived from a dihydroxy compound that has the portion represented by the following general formula (1) as part of the structure thereof and having a glass transition temperature lower than 145°C and a molded polycarbonates resin article obtained by molding the composition. The polycarbonate resin composition gives a molded object having a thickness of 3 mm which has a total light transmittance of 60% or higher.
    本发明旨在提供一种聚碳酸树脂组合物和一种模塑聚碳酸树脂制品,它们兼具优异的透明度和强度,适用于建筑材料领域、电气/电子领域、汽车领域、光学部件领域等。本发明涉及一种含有聚碳酸树脂和抗冲击强度改性剂的聚碳酸树脂组合物,该聚碳酸树脂含有由二羟基化合物衍生的结构单元,该二羟基化合物的部分结构由以下通式(1)表示,其玻璃化转变温度低于 145°C,本发明还涉及通过模塑该组合物获得的模塑聚碳酸树脂制品。该聚碳酸树脂组合物可制成厚度为 3 毫米的模塑物,其总透光率为 60% 或更高。
  • Substituted aminopropionic derivatives as neprilysin inhibitors
    申请人:Novartis AG
    公开号:EP2594556A1
    公开(公告)日:2013-05-22
    The present invention provides a compound of formula I'; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, B1, X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    本发明提供了一种式 I' 的化合物; 或其药学上可接受的盐,其中 R1、R2、R3、R5、B1、X 和 n 在本文中定义。本发明还涉及一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了药理活性剂和药物组合物的组合。
  • POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF
    申请人:Mitsubishi Chemical Corporation
    公开号:EP2692798A1
    公开(公告)日:2014-02-05
    The present invention provides a polycarbonate resin composition with an excellent balance of weather resistance, impact resistance, light-blocking effect and the like, and a molded article thereof. The present invention relates to a polycarbonate resin composition, comprising: a polycarbonate resin containing a structural unit derived from a dihydroxy compound having a moiety represented by the following formula (1) [provided that a case where the moiety represented by formula (1) is a moiety constituting -CH2-O-H is excluded]; and an elastomer composed of a core•shell structure, wherein a core layer of the elastomer is at least one member selected from the group consisting of an alkyl (meth)acrylate and a (meth)acrylic acid, and a polycarbonate resin molded article obtained by molding the polycarbonate resin composition.
    本发明提供了一种在耐候性、抗冲击性、遮光效果等方面具有良好平衡的聚碳酸树脂组合物及其模塑制品。本发明涉及一种聚碳酸树脂组合物,包括聚碳酸树脂,其结构单元来源于具有下式(1)所代表分子的二羟基化合物[但不包括式(1)所代表的分子是由-CH2-O-H 构成的分子的情况];以及由芯壳结构组成的弹性体,其中弹性体的芯层是至少一种选自烷基(甲基)丙烯酸酯和(甲基)丙烯酸组成的组的成员,以及通过模塑该聚碳酸树脂组合物而获得的聚碳酸树脂模塑制品。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫